CISD named CTE District of Distinction
Jan. 26—Cleburne ISD was recently recognized as a 2025 Career & Technical Education Association of Texas CTE District of Distinction.
"We are so very proud of the District of Distinction honor bestowed upon the CISD CTE department," Assistant Superintendent of Student Services Mark McClure said. " The CTE program in CISD is well respected across the state for the opportunities it provides kids. Of course, this doesn't happen without industry-standard facilities, awesome instructors and leadership and a community that wholeheartedly supports these programs by offering internships and career field experiences that ready our students for career success."
kAm%96 r%t s:DEC:4E @7 s:DE:?4E:@? AC@8C2> 46=63C2E6D @FEDE2?5:?8 42C66C 2?5 E649?:42= 65F42E:@? AC@8C2>D 24C@DD %6I2D] %9:D C64@8?:E:@? :D 56D:8?65 E@ 9@?@C 5:DEC:4ED E92E D9@H 6I6>A=2CJ =6256CD9:A[ :??@G2E:@?[ 2?5 4@>>:E>6?E E@ DEF56?E DF446DD :? E96 H@C@56=D @7 6I46==6?46[ D9@H42D:?8 36DE AC24E:46D 2?5 5C:G:?8 AC@8C6DD :? r%t DE2E6H:56]k^Am
kAm%96 2H2C5 DA@E=:89ED 5:DEC:4ED E92E 6I46= :? AC@G:5:?8 :??@G2E:G6 AC@8C2>D[ AC:@C:E:K:?8 H@C D6ED 9:89 DE2?52C5D 7@C 5:DEC:4ED[ C6BF:C:?8 2 E9@C@F89 2AA=:42E:@? AC@46DD E92E D9@H42D6D :??@G2E:G6 AC@8C2>>:?8[ :?5FDECJ\32D65 46CE:7:42E:@?D[ 2?5 6G:56?46 @7 DEF56?E DF446DD] r=63FC?6 x$s'D 2AA=:42E:@? ?@E @?=J >6E E96D6 C:8@C@FD 4C:E6C:2 3FE 2=D@ DE@@5 @FE 2>@?8 5:DEC:4ED DE2E6H:56]k^Am
kAm"pD 2 >6>36C @7 E96 r2C66C U2>Aj %649?:42= t5F42E:@? pDD@4:2E:@? @7 %6I2D[ 2== D49@@= 5:DEC:4ED 24C@DD E96 DE2E6 H6C6 :?G:E65 E@ DF3>:E 2? 2AA=:42E:@? 7@C E96 5:DEC:4E E@ 36 C64@8?:K65[" r%t s:C64E@C #636442 w6C:?8 D2:5] "%96 2AA=:42E:@? C6BF:C65 6IE6?D:G6 :?7@C>2E:@? C682C5:?8 @FC r2C66C U2>Aj %649?:42= t5F42E:@? AC@8C2> 2E r=63FC?6 2D H6== 2D 'a 6DD2JD] %9:D H2D E96 7:CDE E:>6 7@C 5:DEC:4ED E@ 62C? E9:D 5:DE:?4E:@?] x? E96 DE2E6 @7 %6I2D[ bg D49@@= 5:DEC:4ED 62C?65 E96 5:DE:?4E:@?]"k^Am
kAm%9:D 249:6G6>6?E :D 2 E6DE2>6?E E@ E96 92C5 H@C2?5 565:42E:@? @7 r=63FC?6 x$s 65F42E@CD[ 25>:?:DEC2E@CD[ 2?5 DE277 H9@ DEC:G6 E@ AC@G:56 4FEE:?8\6586 @AA@CEF?:E:6D 7@C DEF56?ED] %9C@F89 E96 5:DEC:4E'D r%t AC@8C2>D[ DEF56?ED 2C6 6>A@H6C65 H:E9 D 7@C :?\56>2?5 42C66CD[ 2=:8?:?8 H:E9 :?5FDECJ ?665D 2?5 4C62E:?8 A2E9H2JD 7@C =:76=@?8 DF446DD]k^Am
kAm%96 r%t AC@8C2> AC@G:56D r=63FC?6 w:89 $49@@= DEF56?ED E96 @AA@CEF?:EJ E@ 6IA=@C6 'b 5:776C6?E 42C66C 4=FDE6CD :? p8C:4F=EFC6[ u@@5[ U2>Aj }2EFC2= #6D@FC46D[ pC49:E64EFC6 U2>Aj r@?DECF4E:@?[ pCED[ p^'[ 2?5 r@>>F?:42E:@?D[ qFD:?6DD[ |2CAj u:?2?46[ t5F42E:@? U2>Aj %C2:?:?8[ w62=E9 $4:6?46[ w@DA:E2=:EJ U2>Aj %@FC:D>[ wF>2? $6CG:46D[ x?7@C>2E:@? %649?@=@8J[ {2H U2>Aj !F3=:4 $6CG:46[ |2?F724EFC:?8[ $%t| 2?5 %C2?DA@CE2E:@?[ s:DEC:3FE:@?[ U2>Aj {@8:DE:4D]k^Am
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
7 days ago
- Yahoo
Ratio Therapeutics Partners with Macrocyclics for Exclusive Manufacturing and Distribution of its Radiopharmaceutical Chelator Platform
BOSTON, June 13, 2025 /PRNewswire/ -- Ratio Therapeutics Inc. (Ratio), a pharmaceutical company employing innovative technologies to develop best-in-class radiopharmaceuticals for cancer treatment and monitoring, announced today that it entered into an agreement granting Macrocyclics Inc. (Macrocyclics) exclusive manufacturing and distribution rights to Ratio's proprietary chelator Macropa™ enabling broad access worldwide. Macropa is a proprietary, best-in-class, bifunctional chelator for Actinium-225 (Ac-225), known for its strong alpha-particle emissions and its use in targeted alpha therapy (TAT) for the treatment of cancer. Macropa can be tethered to small molecules, peptides, and large polypeptides such as proteins and antibodies to enable the development of targeted radiopharmaceuticals for alpha radiotherapy. By rapidly and quantitatively complexing Ac-225 at room temperature, Macropa's unique selectivity and stability for Ac-225 enables simple "one-pot" manufacturing and improves in vivo stability of the resulting compound. "Over the past year, we have been focused on building global scientific awareness and encouraging adoption of our chelator platform across the therapeutic radiopharmaceutical community," said Bill Cupelo, Chief Business Officer of Ratio. "We are proud to see our efforts realized through an expanding global ecosystem of collaborators who can now leverage Macropa to accelerate the development and adoption of radiopharmaceuticals worldwide. By enabling broader access to our platform, we are fostering a global community aligned in the mission to improve patient outcomes through targeted cancer therapies and diagnostics." Incorporated in 1995, Macrocyclics is a CDMO specialized in chelating agents for radiopharmaceuticals and nuclear medicine. The company maintains a broad catalog of bifunctional chelating agents that are used in R&D and clinical programs across the globe. Under the terms of the agreement, researchers from academia and industry may purchase Macropa directly from Macrocyclics, enabling rapid access in many countries including Japan, Canada, Australia and majority of Europe. "Ratio's Macropa is a superior chelator for Ac-225," said Paul Jurek, Ph.D., CEO of Macrocyclics. "The ability to label quickly at room temperature provides a critical advantage, especially when working with proteins or vectors that degrade when heated. We are excited to be the exclusive manufacturer of Macropa and plan to add multiple derivatives to our catalog and provide it under GMP conditions for innovators engaged in clinical research." Macrocyclics is an exhibitor at the 2025 SNMMI Annual Meeting, located in New Orleans, LA from June 21 to June 24. Ratio will also have representatives in attendance and will host a networking event for current and potential Macropa users. About Macrocyclics Macrocyclics, Inc., founded in 1995 with headquarters in Plano, Texas, is a CDMO specializing in chelating agents for radiopharmaceuticals and nuclear medicine. A subsidiary of Orano Med, the company stocks a catalog of products dedicated to chelation technology including bifunctional chelators, magnetic resonance agents, and reactive intermediates. The company supports rapid advancements in the field through its GMP compliant quality system, custom small molecule synthesis capabilities, and expertise in analytical development and characterization. For more information about the company, please visit: About Ratio Therapeutics Ratio Therapeutics Inc. is a clinical-stage pharmaceutical company with the mission to accelerate the development of next-generation precision radiopharmaceuticals for solid tumors and transform oncology treatment paradigms. With headquarters and laboratories in Boston, the company currently employs a growing team of multidisciplinary experts with backgrounds in radiopharmaceutical discovery and development. Ratio's proprietary R&D platforms, Trillium™ and Macropa™, enable the development of fit-for-purpose radiopharmaceuticals for therapy and imaging that possess pharmacokinetic modulation, thereby improving drug availability, tumor delivery, and tumor loading. The company is also currently advancing the development of its first FAP-targeted radiotherapeutic with plans to enter clinical trials this year. Please visit for more information and follow us on Twitter (X) and LinkedIn. For information regarding ordering Macropa, please contact Macrocyclics at info@ View original content to download multimedia: SOURCE Ratio Therapeutics Inc. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Forbes
05-06-2025
- Forbes
AC/DC Reaches A Historic Milestone With The Song That Won't Stop Selling
AC/DC's 'Thunderstruck' reaches 520 weeks on Billboard's Rock Digital Song Sales chart, marking a ... More full decade as a top rock digital seller in the U.S. INDIO, CALIFORNIA - OCTOBER 07: (EDITORIAL USE ONLY) Angus Young of AC/DC performs onstage during the Power Trip music festival at Empire Polo Club on October 07, 2023 in Indio, California. (Photo byfor Power Trip) AC/DC's 'Thunderstruck' is a once-in-a-century kind of hit. The track not only defines the band's time together, but it's also recognized as one of the most successful in hard rock history. Few tunes have come close to matching its ubiquity and commercial success. Decades after its release, the cut remains a staple — and at least in the United States, it's a consistent bestseller. This week is especially notable for 'Thunderstruck' on one Billboard ranking, as it reaches a milestone that very few compositions will come close to achieving. On the latest edition of the Rock Digital Song Sales chart — the Billboard tally that ranks the bestselling rock-only tracks in the nation — 'Thunderstruck' climbs from No. 15 to No. 9. As it holds on, and even improves, the tune celebrates 520 frames on the list. This period makes it a complete decade as one of the top-selling cuts in that style in the largest music market in the world. 'Thunderstruck' is AC/DC's first track to spend 520 weeks on the Rock Digital Song Sales chart. It's easily the band's longest-running success. The runner-up, 'Back in Black,' has only managed to remain on the tally for 127 stays. 'Thunderstruck' eclipses that total four times over. Those two titles are the only ones in the group's discography to make it to triple digit stays on this purchases-only roster. 'Thunderstruck' surpasses every other smash AC/DC has sent to the Rock Digital Song Sales chart throughout the years. The group has pushed 19 tunes onto the tally, and the other 18 have combined for 224 weeks on the list. That's less than half as long as 'Thunderstruck' has held on. The generation-defining smash also outpaces every other top 10 hit on the current edition of the Rock Digital Song Sales tally. Combined, those nine tunes have accumulated 146 weeks on the ranking — while 'Thunderstruck' beats that figure three-and-a-half times over, and still manages to rejoin the loftiest tier on the list. 'Thunderstruck' isn't only succeeding on the Rock Digital Song Sales chart this week. It also appears inside the top 10 on both the Hard Rock Streaming Songs and Hard Rock Digital Song Sales tallies as well.
Yahoo
05-06-2025
- Yahoo
Boise to welcome ‘crown jewel' of hotels on Grove Street. What's coming?
The newest hotel in downtown Boise is edging closer to opening in an area that has seen a wild transformation since the COVID-19 pandemic. Construction crews, city officials, businessmen and developers celebrated a 'topping off' ceremony Wednesday for the incoming 15-story, dual-branded AC and Element Marriott hotel at 1011 W. Grove St. Attendees signed the final structural beam before a crane lifted it atop the building. The AC Hotel will offer a 'sleek, modern experience' with a European style, while the Element Hotel will focus on 'wellness, sustainability and extended-stay comfort,' said Mike Webster, the president of Eagle's Pennbridge Hospitality, which is building the hotels. The two hotels will be within the same building with a shared lobby. The 175-room AC will offer a minimalist experience, while all rooms in the 121-room Element will have kitchens and complimentary breakfasts. 'We think we're bringing something truly unique to the Boise market,' Webster said. The estimated $100 million hotel will include 296 rooms with 10 suites, 9,000 square feet of meeting space, a fitness center and an outdoor roof deck with a spa, barbecues and fire pits on the fifth floor. On the 16th floor, the hotel will include a full-service restaurant and bar called the Boise Post flanked by two rooftop decks. According to Tom Whitney, vice president of development at Pennbridge, the restaurant will use local ingredients in global dishes — such as a Thai larb salad with smoked Idaho trout or churros with Idaho potato flour. The restaurant will be open to the public, too. 'This will really be a crown jewel of the Boise hotel scene,' Whitney said. 'This property will be a landmark.' The building has been under construction for 17 months, and it still has about nine months until crews finish, Whitney said. The hotel is Pennbridge's 14th and its fifth in Idaho. The company's portfolio includes two hotels in Twin Falls, two Marriott hotels in Boise and the 10-story Residence Inn that opened on Capitol Boulevard in October 2017. The new hotel will 'be a great compliment' to the Residence Inn, said Tom Lewis, one of two principals and cofounders of Pennbridge along with Jared Smith. The building has been a long-time coming. The company bought the parking lot that filled the site in January 2020, according to Smith. Then the pandemic hit two months later, parking revenue went to zero, and the duo questioned what they were doing. 'The sun is much brighter in June of 2025 than it was in June of 2020,' Smith said. In that period, a wave of new hotels and redevelopment swept through downtown Boise — focusing heavily on properties surrounding the 11th and Grove street intersection where the AC and Element Hotel is going up. The 122-room Hotel Renegade opened on the northwest corner in May 2024, followed two months later by the boutique Sparrow hotel with 66 rooms on the northeast corner. Both Hotel Renegade and the AC and Element hotels filled former parking lots. Mayor Lauren McLean said the new hotels are helping link the core of downtown to other parts of downtown along Grove Street. 'We have seen so much progress and development right here in an area that was pretty quiet just a couple years ago at the beginning of COVID,' McLean said at the event. 'And it has come to life.' Cody Lund, the executive director of the Boise Centre, told the Idaho Statesman after the Sparrow opened that the city continues to see more demand than hotels have room for. The new Pennbridge hotel could make a dent in that demand, but local hoteliers say the city is still lacking a large-scale hotel with 600 rooms or more that could help bring in bigger conventions or events. The 296 rooms of the new hotel would get close, but not surpass, the largest hotel in the Greater Boise Auditorium District's boundaries: the Riverside Hotel in Garden City, with 300 rooms. But it would dethrone the largest in Boise: the Grove Hotel on Boulevard, with 250 rooms. Thought shopping malls were dead? This developer wants to bring one back to life As Boise area grapples with change, more homes get OK for busy transit corridor Harris Ranch could soon add businesses, shopping & food carts. What's the plan? A historic Boise home could be demolished over safety concerns. What happened?
